Literature DB >> 18821687

An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis.

A K Brown1, P G Conaghan, Z Karim, M A Quinn, K Ikeda, C G Peterfy, E Hensor, R J Wakefield, P J O'Connor, P Emery.   

Abstract

OBJECTIVE: Achieving remission is the aim of treatment in rheumatoid arthritis (RA). This should represent minimal arthritis activity and ensure optimal disease outcome. However, we have previously demonstrated a high prevalence of imaging-detected synovial inflammation in RA patients who were in clinical remission. The purpose of this study was to evaluate the long-term significance of subclinical synovitis and its relationship to structural outcome.
METHODS: We studied 102 RA patients receiving conventional treatment who had been judged by their consultant rheumatologist to be in remission, as well as 17 normal control subjects. Subjects underwent clinical, laboratory, functional, and quality of life assessments over 12 months. In addition to standard radiography of the hands and feet, imaging of the hands and wrists was performed with musculoskeletal ultrasonography (US) and conventional 1.5 T magnetic resonance imaging (MRI) at baseline and 12 months, using validated acquisition and scoring techniques.
RESULTS: Despite their being in clinical remission, 19% of the patients displayed deterioration in radiographic joint damage over the study period. Scores on musculoskeletal US synovial hypertrophy, power Doppler (PD), and MRI synovitis assessments in individual joints at baseline were significantly associated with progressive radiographic damage (P=0.032, P<0.001, and P=0.002, respectively). Furthermore, there was a significant association between the musculoskeletal US PD score at baseline and structural progression over 12 months in totally asymptomatic metacarpophalangeal joints (P=0.004) and 12 times higher odds of deterioration in joints with increased PD signal (odds ratio 12.21, P<0.001).
CONCLUSION: Subclinical joint inflammation detected by imaging techniques explains the structural deterioration in RA patients in clinical remission who are receiving conventional therapy. Our findings reinforce the utility of imaging for the accurate evaluation of disease status and the prediction of structural outcome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18821687     DOI: 10.1002/art.23945

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  217 in total

1.  Factors influencing ultrasonographic remission in patients with rheumatoid arthritis.

Authors:  Halil Harman; Ibrahim Tekeoğlu; Nedim Kaban; Sibel Harman
Journal:  Rheumatol Int       Date:  2014-11-16       Impact factor: 2.631

2.  Imaging in rheumatology: ultrasafe + ultrasure = ultrasound.

Authors:  Oscar Epis; Luca Giacomelli; Eleonora Bruschi
Journal:  Rheumatol Int       Date:  2012-03-24       Impact factor: 2.631

Review 3.  My treatment approach to rheumatoid arthritis.

Authors:  John M Davis; Eric L Matteson
Journal:  Mayo Clin Proc       Date:  2012-07       Impact factor: 7.616

4.  Brief history parallel to the enthusiasm showed by rheumatologists at the American College of Rheumatology meeting for the musculoskeletal ultrasound.

Authors:  Angel Checa
Journal:  Rheumatol Int       Date:  2010-05-27       Impact factor: 2.631

5.  Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients.

Authors:  Roxana Coras; Gustavo Añez Sturchio; Mireia Barceló Bru; Agustí Sellas Fernandez; Sandra Farietta; Salvador Campos Badia; Basilio Rodríguez Diez; Juan José de Agustín de Oro
Journal:  Eur J Rheumatol       Date:  2020-07-21

6.  MRI assessment of erosion repair in patients with long-standing rheumatoid arthritis receiving double-filtration plasmapheresis in addition to leflunomide and methotrexate: a randomized controlled trial.

Authors:  Xiaoxia Yu; Lei Zhang; Lixin Wang; Weiwei Lu; Fengyan Sun; Ping Xu; Guobin Lan
Journal:  Clin Rheumatol       Date:  2018-01-08       Impact factor: 2.980

7.  Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis.

Authors:  Fawaz Y Azizieh; Khaled Al Jarallah; Diaa Shehab; Renu Gupta; Kamaludin Dingle; Raj Raghupathy
Journal:  Rheumatol Int       Date:  2017-07-19       Impact factor: 2.631

8.  Presence of power Doppler synovitis in rheumatoid arthritis patients with synthetic and/or biological disease-modifying anti-rheumatic drug-induced clinical remission: experience from a Chinese cohort.

Authors:  Yan Geng; Jingjing Han; Xuerong Deng; Zhuoli Zhang
Journal:  Clin Rheumatol       Date:  2014-04-29       Impact factor: 2.980

Review 9.  The role of biomarkers in the management of patients with rheumatoid arthritis.

Authors:  Jackie Nam; Edith Villeneuve; Paul Emery
Journal:  Curr Rheumatol Rep       Date:  2009-10       Impact factor: 4.592

Review 10.  Using ultrasonography to facilitate best practice in diagnosis and management of RA.

Authors:  Andrew K Brown
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.